Contact Information
• Your name, degree, institution, address, phone number, and email address must be provided. As the corresponding author, you will receive all future correspondence from ACMG.
• The submitting author should be the first author (presenter) of the abstract, unless otherwise noted during submission.

Co-Authors
• Names of co-authors and institutions must be provided. Changes will not be made to the spelling of authors’ names after the submission deadline; please proof your co-authors’ names carefully.

Copyright Policy
• All authors must assign copyright of the abstract to ACMG, unless one of the authors is a U.S. Federal employee (in such case, ACMG does not hold copyright).

Abstract Title
• The abstract title should be brief and clearly indicate the nature of the abstract. You may use up to 20 words.
• The abstract title must be in title case. Capitalize all nouns, pronouns, adjectives, verbs, adverbs, and subordinate conjunctions (i.e., as, because, although). Except for the first word of the title, lowercase all articles, coordinate conjunctions (i.e., and, or, nor), and prepositions, regardless of length. Also, lowercase “to” when used as an infinitive. See examples here.
• Additionally, keep letters lowercase if the lowercase letters have a specific meaning, such as aCGH.
• Do not put a period at the end of the title.
•For example: Cancer Genetics: Translation of New Concepts to Clinical Care

Use of Product Names
• Non-proprietary (generic/scientific) names should be used and should be lowercase.
• If necessary, you may include a proprietary name in parentheses directly following the generic name after its first mention in the body of the abstract; the first letter of the name of a proprietary drug should be capitalized. ACMG reserves the right to replace proprietary names with generic names to adhere to this policy.
Abbreviations • Use standard abbreviations. Place abbreviations in parentheses immediately after the first mention of a term or phrase; the abbreviation can then be used throughout the abstract.

Abstract Body, Tables, and Figures
• Abstracts submitted for the ACMG annual meeting are published online. It is the responsibility of the author to proofread the abstract carefully.
• You are allotted 4,200 characters (excluding spaces) for your abstract. The program will not allow submission if the maximum number is exceeded. 
• The abstract may be structured (i.e.abstracts divided into sections using terms such as Introduction, Methods, Results, Conclusions, etc.) or unstructured.
• Do not use bold type or underline formatting. Italic type is acceptable.
• Text may be in multiple paragraphs.
• Special Greek and mathematical symbols are available in a character map within the submission system.
• Use numerals to indicate numbers, except when beginning sentences.
• Simple tables and graphs may be included. The online abstract submission system provides step-by-step instructions on inserting tables and graphs in the preferred HTML format.
• Any references should be noted as citations within the text and not as footnotes at the end.<

PerkinElmer Diagnostics Company Travel Award - Suspended for 2021

The ACMG Foundation for Genetic and Genomic Medicine/ PerkinElmer Diagnostics Company Travel Award is given to a selected student, trainee, or junior faculty ACMG member whose abstract submission is chosen as a platform presentation during the 2021 ACMG Annual Clinical Genetics Meeting. In recognition of their selected presentation, PerkinElmer Diagnostics Company covers the travel costs for the recipient to the meeting.

How to be considered for the PerkinElmer Diagnostics Company Travel Award:
• All geneticists-in-training, who are both first author and presenter of the abstract, are automatically considered for an Abstract Award. Therefore, you must first identify as a geneticist–in-training and then select the appropriate training category (undergraduate student, medical student, graduate student, resident physician, or post-doctoral fellow) in the online abstract submission system.
• As a geneticist-in-training, you are required to submit a letter from the senior investigator overseeing your research confirming your status as a geneticist-in-training.
• Your letter must be typed on your institution’s letterhead, signed by the senior investigator, saved in PDF format, and uploaded to the online abstract submission system.
• Please include the following items in your letter:
o Author name (this is the geneticist-in-training who is the presenting/contact author)
o Confirmation of your status as a geneticist-in-training

All geneticist-in-training authors must upload the required letter into the abstract submission system in order to complete the abstract submission. The deadline for receipt of the geneticist-in-training letter is, therefore January 15, 2021. There will be no exceptions.

• Abstract Award recipients will be notified if they will receive an award the week of February 8, 2021. You must attend the meeting and present your abstract to receive your award.

David L. Rimoin Inspiring Excellence Award

The ACMG Foundation for Genetic and Genomic Medicine will issue the David L. Rimoin Inspiring Excellence Award given to a selected student, trainee, or junior faculty ACMG member whose abstract submission is chosen as a platform presentation during the 2021 ACMG Annual Clinical Genetics Meeting. In recognition of their selected presentation, The Rimoin Fund covers the travel costs for the recipient to attend the meeting.

How to be considered for the David L. Rimoin Inspiring Excellence Award:
• All geneticists-in-training, who are both first author and presenter of the abstract, are eligible to be considered for an Abstract Award. Therefore, you must first identify as a geneticist–in-training and then select the appropriate training category (undergraduate student, medical student, graduate student, resident physician, or post-doctoral fellow) in the online abstract submission system.
• As a geneticist-in-training, you are required to submit a letter from the senior investigator overseeing your research confirming your status as a geneticist-in-training. The deadline for receipt of the geneticist-in-training letter is, therefore, January 8, 2021. There will be no exceptions.
• Your letter must be typed on your institution’s letterhead, signed by the senior investigator, saved in PDF format, and uploaded to the online abstract submission system.
• Please include the following items in your letter:
o Author name (this is the geneticist-in-training who is the presenting/contact author)
o Confirmation of your status as a geneticist-in-training
• Abstract Award recipients will be notified if they will receive an award the week of February 8, 2021. You must attend the meeting and present your abstract to receive your award.

Eligible candidates interested in entering the competition will indicate so during the abstract submission process.


Carolyn Mills Lovell Genetic Counselors Award

ACMG supports special recognition and a Carolyn Mills Lovell Genetic Counselors award for a high-scoring abstract submitted by a genetic counselor.

The ACMG Foundation for Genetic and Genomic Medicine will be giving the Carolyn Mills Lovell Genetic Counselors Award to the first author of the highest rated genetic counselor-authored abstract submission for the scientific program during the 2021 ACMG Annual Clinical Genetics Meeting.

How to be considered for the Carolyn Mills Lovell Genetic Counselors Award

Applicants must be certified or board-eligible Genetic Counselors or genetic counseling graduate students enrolled in an accredited genetic counseling training program and do not have to be an ACMG member.

Eligible candidates interested in entering the competition will indicate so during the abstract submission process.

The Carolyn Mills Lovell Genetic Counselors Award will be presented to the recipient at the 2021 ACMG Annual Clinical Genetics Meeting. In recognition of their selected presentation, a $1000 cash award will be given to the recipient.
 

Completion of all required disclosure information in the online abstract submission system serves as an agreement and is accepted in lieu of a faxed signature. It certifies the ACMG abstract submitter's understanding of the rules for participation contained in the online abstract submission program and affirms that:
• 1. All authors approve of submitting this work for presentation and publication;
• 2. The author(s) transfer(s) all copyright ownership of the named abstract to the American College of Medical Genetics and Genomics (except when one or more authors are U.S. Government employees);
•3. Submitter is acting on behalf of authors and has read the ACMG Conflict-of-Interest Policy and has acted in accordance with that policy;
•4. The author(s) agree(s) to materially confine the presentation to information in the abstract, if accepted for presentation. If an author has more than one abstract accepted, each presentation will be materially confined to the information in the abstract selected for the specific session;
•5. The presenting author will be available to present the abstract if selected for the program. The author(s) will immediately notify ACMG if the first author is not the presenting author.

Send related correspondence and questions regarding abstract submissions or notifications to Education@ACMG.net.

ACMG Annual Meeting Registration

• Please note that submitting an abstract does not register you for the ACMG annual meeting.
• To register, you must complete and return an Attendee Registration Form, or register online through the ACMG Meeting website.